Turmeric and digestive complaints

Overall digestive complaint score and individual symptoms in the Curcugen study.

Key points

  • In adults with self-reported digestive complaints, the overall complaint score decreased more over eight weeks with Curcugen than placebo. For Curcugen there is a preliminary signal of a possible reduction in overall digestive discomfort. [1] See the evidence 1
  • In the same study no advantage was found for individual complaint types or overall quality of life. A confirmed improvement in every individual symptom should not be expected. [1] See the evidence 1

Practical guide

Check the conclusions and whether they apply to your situation.

Overall complaint score and individual symptoms were assessed separately.

Key points

Why these conclusions

The Curcugen study

Adults with self-reported digestive complaints received 500 mg Curcugen daily or placebo for eight weeks. Overall complaint score decreased more with Curcugen; no advantage was found for individual complaint types or overall quality of life. [1]

Turmeric and curcumin supplements may cause nausea, reflux, diarrhea or constipation. [2]

Overall digestive complaint score decreased more with Curcugen than placebo over eight weeks.

ParameterData
ResultOverall digestive complaint score decreased more with Curcugen than placebo over eight weeks. Mean 2.91→2.10 versus 2.65→2.18; group×time interaction p=0.021, ES 0.57.
Participants79 adults with self-reported gastrointestinal complaints, 38 and 39 with questionnaire data
FormOral Curcugen extract, 50% curcuminoids in formula
Dose500 mg product/day
Dose basis500 mg product/day
Comparatorplacebo
Duration8 weeks
Confidence2/4: Precision: No confidence interval for direct contrast in extraction. Consistency: No grounds for a separate downgrade. Applicability to the specified group: Measurement directly addresses the stated narrow study question. Possible publication bias: No specific data for a separate downgrade. Study methods: Small sample and author ties to manufacturer.
Evidence base1 randomized trial (79 randomized, 77 with questionnaire data; overall score and subscales are one trial)
Sources[1]

No advantage of Curcugen over placebo was found for individual types of digestive complaints or overall quality of life.

ParameterData
ResultNo advantage of Curcugen over placebo was found for individual types of digestive complaints or overall quality of life. Authors found no significant group interactions for individual subscales or overall quality of life; abdominal pain p=0.124.
Participants77 adults with self-reported digestive complaints
FormOral Curcugen extract, 50% curcuminoids in formula
Dose500 mg product daily
Dose basis500 mg product daily
Comparatorplacebo
Duration8 weeks
Confidence1/4: Precision: Confidence interval for the direct contrast was not extracted or concerns group means. Consistency: No grounds for a separate downgrade. Applicability to the specified group: Exact protocol and specific formula. Possible publication bias: No specific data for a separate downgrade. Study methods: Small groups, multiple outcomes or completer analysis.
Evidence base1 randomized trial (79 randomized, 77 with questionnaire data; overall score and subscales are one trial)
Sources[1]

Turmeric and curcumin supplements may cause nausea, reflux, diarrhea or constipation.

Turmeric and curcumin supplements may cause nausea, reflux, diarrhea or constipation. [2]

More details

How to understand the results

The preliminary signal applies to the overall score and studied extract; individual subscales and quality of life were assessed separately. [1]

Sources

  1. Efficacy of a curcumin extract (Curcugen™) on gastrointestinal symptoms and intestinal microbiota in adults with self-reported digestive complaints: a randomised, double-blind, placebo-controlled study. https://pubmed.ncbi.nlm.nih.gov/33478482/
  2. NCCIH Turmeric: Usefulness and Safety. https://www.nccih.nih.gov/health/turmeric

Methodology: Subpages evidence-led supplement pipeline v1

Ingredient overview: Curcuma longa